Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC

Fan Zhang, Wei Guo, Bolun Zhou, Shuhang Wang, Ning Li, Bin Qiu, Fang Lv, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Shugeng Gao*, Jie He

*此作品的通讯作者

科研成果: 期刊稿件 › 文章 › 同行评审

41 引用 （Scopus）

指纹

探究 'Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC' 的科研主题。它们共同构成独一无二的指纹。

Medicine and Dentistry